welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
Researchers

Richard J. Barohn, MD

Researcher
Executive Vice Chancellor for Health Affairs
University of Missouri
1020 Hitt Street
Columbia, Missouri, United States

Richard J. Barohn, MD, treats patients with neurological and neuromuscular diseases, such as amyotrophic lateral sclerosis (ALS), muscular dystrophy and myasthenia gravis. Most recently, he served as the chair of the Department of Neurology and the vice chancellor of research at the University of Kansas Medical Center. He is MU’s top health administrator — the executive vice chancellor of health affairs — and the executive scientific director of the NextGen Precision Health Institute. In his free time, Dr. Barohn enjoys following sports, especially the Kansas City Royals, and supporting local artists by adding to his collection of paintings and sculptures.

Barohn earned a medical degree from the University of Missouri-Kansas City in 1980. He completed his residency in neurology at the Wilford Hall U.S. Air Force Medical Center in San Antonio, Texas, as well as a fellowship training in neuromuscular diseases at The Ohio State University.

Dr. Barohn was the principal investigator on the prestigious National Institutes of Health Clinical and Translational Science Award and the NeuroNEXT grant at KU Medical Center. He was the director of KU’s institute for clinical and translational research.

Representative Publications:

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report

Ataluren treatment of patients with nonsense mutation dystrophinopathy

rareRelated